Holen Sie sich die Stockscreener-App
1.46
2.82%
0.04
Handel nachbörslich:
1.43
-0.03
-2.05%
Schlusskurs vom Vortag:
$1.42
Offen:
$1.41
24-Stunden-Volumen:
77,629
Relative Volume:
0.26
Marktkapitalisierung:
$7.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.91M
KGV:
-0.4479
EPS:
-3.26
Netto-Cashflow:
$-6.14M
1W Leistung:
+0.69%
1M Leistung:
-24.55%
6M Leistung:
-42.06%
1J Leistung:
-57.81%
1-Tages-Spanne:
$1.38
$1.4749
1-Wochen-Bereich:
$1.3218
$1.5383
52-Wochen-Spanne:
$1.15
$23.80
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Firmenname
Galmed Pharmaceuticals Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GLMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.46 | 7.92M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-05-22 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | Eingeleitet | Craig Hallum | Buy |
| 2020-01-30 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-12-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-08-02 | Bestätigt | Maxim Group | Buy |
| 2018-07-13 | Eingeleitet | Stifel | Buy |
| 2018-07-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-06-12 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-15 | Hochstufung | Maxim Group | Hold → Buy |
| 2018-02-14 | Herabstufung | Maxim Group | Buy → Hold |
| 2018-02-12 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Eingeleitet | ROTH Capital | Buy |
| 2017-08-08 | Bestätigt | H.C. Wainwright | Buy |
| 2017-07-31 | Bestätigt | Maxim Group | Buy |
| 2016-08-01 | Bestätigt | Maxim Group | Buy |
| 2016-07-06 | Fortgesetzt | ROTH Capital | Buy |
| 2016-03-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-05-06 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Galmed Pharmaceuticals Ltd Aktie (GLMD) Neueste Nachrichten
Analyzing Galmed Pharmaceuticals Ltd. with multi timeframe charts2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Volatility clustering patterns for Galmed Pharmaceuticals Ltd.Weekly Volume Report & Fast Entry and Exit Trade Plans - Newser
Why Galmed Pharmaceuticals Ltd. is moving todayPortfolio Risk Report & Weekly Watchlist of Top Performers - Newser
What’s next for Galmed Pharmaceuticals Ltd. stock priceWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Can Galmed Pharmaceuticals Ltd. hit a new high this monthWeekly Market Outlook & Daily Volume Surge Trade Alerts - Newser
Historical volatility pattern of Galmed Pharmaceuticals Ltd. visualized2025 Technical Overview & Stock Portfolio Risk Management - Newser
Is Galmed Pharmaceuticals Ltd. Stock a Good Fit for Conservative InvestorsChart Pattern Strategy with ROI Focus - Newser
Is Galmed Pharmaceuticals Ltd. showing signs of accumulationFree Stock Screener With Smart Filters - Newser
What machine learning models say about Galmed Pharmaceuticals Ltd.Market Liquidity and Price Flow Analysis - Newser
How to recover losses in Galmed Pharmaceuticals Ltd. stockDaily Technical Chart Pattern Analysis Report - Newser
Galmed Pharmaceuticals (NASDAQ:GLMD) Raised to Hold at Wall Street Zen - Defense World
Is Galmed Pharmaceuticals Ltd. still worth holding after the dipDaily Pattern Analysis with Return Forecast - Newser
Short Interest in Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Expands By 49.9% - Defense World
Quantitative breakdown of Galmed Pharmaceuticals Ltd. recent moveVolume Spike Detection for Early Breakouts - Newser
What moving averages say about Galmed Pharmaceuticals Ltd.Swing Trade Watchlist with Entry Zones - Newser
How Galmed Pharmaceuticals Ltd. stock performs during market volatilityHistorical Market Behavior and Trend Summary - Newser
Short Term Trend Reversal in Galmed Pharmaceuticals Ltd. PossibleHigh Accuracy Alerts for ROI Traders Detected - beatles.ru
Technical signs of recovery in Galmed Pharmaceuticals Ltd.High Conviction Stock Long-Term Summary - Newser
Investors Hope for Bounce in Galmed Pharmaceuticals Ltd. After Selloff - metal.it
Why Galmed Pharmaceuticals Ltd. stock attracts strong analyst attentionNear-Term Market Opportunity Forecast Sheet - Newser
Is it the right time to buy Galmed Pharmaceuticals Ltd. stockMaximize returns with strategic portfolio planning - Jammu Links News
How does Galmed Pharmaceuticals Ltd. compare to its industry peersHigh-octane financial growth - Jammu Links News
What is Galmed Pharmaceuticals Ltd. company’s growth strategyConsistently outstanding ROI - Jammu Links News
What are Galmed Pharmaceuticals Ltd. company’s key revenue driversMaximize portfolio value with expert tips - Jammu Links News
Is Galmed Pharmaceuticals Ltd. stock overvalued or undervaluedAccelerated wealth expansion - Jammu Links News
What drives Galmed Pharmaceuticals Ltd. stock priceUnlock daily stock market insights for success - Jammu Links News
Is Galmed Pharmaceuticals Ltd. a good long term investmentUnmatched profit potential - Jammu Links News
Should I hold or sell Galmed Pharmaceuticals Ltd. stock in 2025Accelerated financial growth - Jammu Links News
What are analysts’ price targets for Galmed Pharmaceuticals Ltd. in the next 12 monthsAccess high-quality stock research instantly - Jammu Links News
What is the risk reward ratio of investing in Galmed Pharmaceuticals Ltd. stockUnmatched market performance - Jammu Links News
Why is Galmed Pharmaceuticals Ltd. stock attracting strong analyst attentionFree Expert Stock Watchlist - Jammu Links News
When is Galmed Pharmaceuticals Ltd. stock expected to show significant growthBuild a winning investment portfolio - Jammu Links News
Identifying reversal signals in Galmed Pharmaceuticals Ltd.Deep Learning Stock Forecast for Investors - Newser
What catalysts could drive Galmed Pharmaceuticals Ltd. stock higher in 2025Exceptional gains - Jammu Links News
Galmed Pharmaceuticals (NASDAQ:GLMD) Cut to Sell at Wall Street Zen - Defense World
What are the technical indicators suggesting about Galmed Pharmaceuticals Ltd.Achieve breakthrough financial results - Jammu Links News
What is the dividend policy of Galmed Pharmaceuticals Ltd. stockMarket Forecast Signals For Fast Growth - Jammu Links News
Finanzdaten der Galmed Pharmaceuticals Ltd-Aktie (GLMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):